Pearl River Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,920	Closed	-$220K	–	405
2024 Q1	$220K	Sell	11,920 -21,245	-64%	-$526K	0.03%	429
2023 Q4	$1.04M	Buy	33,165 +1,536	+5%	+$36.7K	0.17%	192
2023 Q3	$659K	Buy	31,629 +2,773	+10%	+$75.3K	0.1%	283
2023 Q2	$691K	Sell	28,856 -2,760	-9%	-$61.3K	0.11%	270
2023 Q1	$595K	Buy	31,616 +14,324	+83%	+$273K	0.09%	288
2022 Q4	$275K	Sell	17,292 -12,826	-43%	-$200K	0.05%	424
2022 Q3	$493K	Buy	30,118 +16,131	+115%	+$261K	0.09%	290
2022 Q2	$197K	Sell	13,987 -9,461	-40%	-$177K	0.05%	412
2022 Q1	$568K	Buy	23,448 +14,059	+150%	+$340K	0.16%	206
2021 Q4	$219K	Buy	+9,389	New	+$189K	0.06%	363
2021 Q1	–	Sell	-7,153	Closed	-$382K	–	377
2020 Q4	$382K	Sell	7,153 -8,463	-54%	-$420K	0.14%	233
2020 Q3	$644K	Buy	15,616 +11,171	+251%	+$482K	0.27%	126
2020 Q2	$215K	Buy	+4,445	New	+$213K	0.11%	244
2019 Q1	–	Sell	-718	Closed	-$12K	–	344
2018 Q4	$12K	Buy	+718	New	+$13.9K	0.06%	468